EU Cosmetic Safety Compliance: CPNP Registration Completed
2025. 9. 2.
All MOSTIA products have successfully completed registration with the EU Cosmetic Product Notification Portal (CPNP), the European cosmetic safety management system.
This confirms that the essential requirements for entering the European market have been fully met and marks an important milestone in strengthening MOSTIA’s global competitiveness.
Moving forward, MOSTIA will continue to expand into international markets through systematic quality control aligned with country-specific regulations.
ISO 9001 & ISO 14001 Certifications Achieved
2025. 10. 9.
MOSTIA has successfully obtained both ISO 9001 certification for quality management systems and ISO 14001 certification for environmental management systems.
Beyond product quality, this achievement officially recognizes MOSTIA’s brand philosophy of operating with consideration for environmental responsibility.
MOSTIA will continue to pursue sustainable beauty and grow as a responsible brand for the future.
U.S. FDA MoCRA Registration Completed
2025. 10. 9.
MOSTIA has successfully completed registration under the U.S. cosmetic safety regulation, FDA MoCRA, establishing a quality management system that meets global standards.
This certification reflects a comprehensive review covering ingredient management, manufacturing processes, and product safety, demonstrating MOSTIA’s reliability as a trusted brand in international markets.
Moving forward, MOSTIA will continue to uphold global-standard quality management and connect with customers across a wider range of markets.
All MOSTIA Products Certified as Non-Irritating in Skin Low-Irritation Tests
2025. 11. 1.
All three MOSTIA products—toner, serum, and cream—have received non-irritating certification through skin low-irritation testing.
Designed for comfortable use even on sensitive skin, the results confirm that careful consideration of every ingredient and the overall user experience has been objectively verified through clinical testing.
MOSTIA is committed to delivering skincare that includes only what the skin truly needs, making it safe for everyday use without burden.
Moving forward, MOSTIA will continue to stand alongside customers as a brand that places skin safety first.
Clinical Trials Completed for MOSTIA’s Three Products: Skin Barrier, Hydration & Trouble Care
2025. 10. 9.
All three MOSTIA products have successfully completed clinical trials tailored to their respective functions.
The toner demonstrated improvements in the skin barrier, the serum showed suitability for trouble-prone skin, and the cream verified its moisturizing efficacy—clearly confirming each product’s distinct role and performance.
MOSTIA aims to deliver skincare that goes beyond a pleasant texture, enabling users to truly experience visible skin improvements.
Moving forward, MOSTIA will continue rigorous testing and verification to uphold this commitment.